ATE299593T1 - Verfahren zum screenen von pflanzenextrakten nach wirkstoffen - Google Patents

Verfahren zum screenen von pflanzenextrakten nach wirkstoffen

Info

Publication number
ATE299593T1
ATE299593T1 AT01110765T AT01110765T ATE299593T1 AT E299593 T1 ATE299593 T1 AT E299593T1 AT 01110765 T AT01110765 T AT 01110765T AT 01110765 T AT01110765 T AT 01110765T AT E299593 T1 ATE299593 T1 AT E299593T1
Authority
AT
Austria
Prior art keywords
active ingredients
biologically active
extract
plant
plant extracts
Prior art date
Application number
AT01110765T
Other languages
English (en)
Inventor
Li-Wei Hsu
Su-Chen Chang
Original Assignee
Advanced Gene Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Gene Technology Corp filed Critical Advanced Gene Technology Corp
Application granted granted Critical
Publication of ATE299593T1 publication Critical patent/ATE299593T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01110765T 2000-11-07 2001-05-03 Verfahren zum screenen von pflanzenextrakten nach wirkstoffen ATE299593T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70830600A 2000-11-07 2000-11-07

Publications (1)

Publication Number Publication Date
ATE299593T1 true ATE299593T1 (de) 2005-07-15

Family

ID=24845266

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01110765T ATE299593T1 (de) 2000-11-07 2001-05-03 Verfahren zum screenen von pflanzenextrakten nach wirkstoffen
AT01112092T ATE299374T1 (de) 2000-11-07 2001-05-29 Adenosine als antithrombosemittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01112092T ATE299374T1 (de) 2000-11-07 2001-05-29 Adenosine als antithrombosemittel

Country Status (7)

Country Link
US (1) US20020082241A1 (de)
EP (2) EP1205754B1 (de)
CN (2) CN1352945A (de)
AT (2) ATE299593T1 (de)
AU (1) AU5178801A (de)
CA (1) CA2348845A1 (de)
DE (2) DE60111906D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855343B2 (en) * 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
CN106501415A (zh) * 2016-12-02 2017-03-15 丽珠集团丽珠制药厂 一种阿魏酸钠、阿司匹林、桂利嗪和维生素b1的含量测定方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
WO1991011458A1 (en) * 1990-02-02 1991-08-08 Genentech, Inc. CYCLIC PEPTIDES CONTAINING Arg-Gly-Asp FLANKED BY PROLINE
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
JP3002903B2 (ja) * 1991-04-09 2000-01-24 第一化学薬品株式会社 血管外血液の抗凝固・抗血小板剤組成物及びこれを用いる血小板活性化の分子マーカーの測定法
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
DE19802576B4 (de) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
US6713309B1 (en) * 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture

Also Published As

Publication number Publication date
EP1205182A2 (de) 2002-05-15
EP1205754A2 (de) 2002-05-15
EP1205754B1 (de) 2005-07-13
EP1205182B1 (de) 2005-07-13
CN1220060C (zh) 2005-09-21
AU5178801A (en) 2002-05-09
US20020082241A1 (en) 2002-06-27
DE60111905D1 (de) 2005-08-18
EP1205754A3 (de) 2002-07-17
CA2348845A1 (en) 2002-05-07
CN1353003A (zh) 2002-06-12
ATE299374T1 (de) 2005-07-15
DE60111906D1 (de) 2005-08-18
EP1205182A3 (de) 2002-09-04
CN1352945A (zh) 2002-06-12

Similar Documents

Publication Publication Date Title
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
SE9803838D0 (sv) A chromatography method and a column material useful in said method
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
DE69715204T2 (de) Verfahren zur fraktionierung einer lösung durch ein simuliertes wanderbett chromatographieverfahren
DE60231651D1 (de) Proteinreinigungsverfahren
MEP32608A (en) Antibodies to opgl
DE69229267D1 (de) Verfahren und zubereitungen zur isolierung von taxanen
DE69700902D1 (de) Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
DE69933369D1 (en) Adressierbare protein arrays
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
DK0547165T3 (da) Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
Nojiri et al. Qualitative and quantitative analysis of endogenous jasmonic acid in bulbing and non-bulbing onion plants
DE69610716D1 (de) Topiramate-immunoassay, sowie analoge und antikörper
BR9407422A (pt) Kit de ensaio
DK1019420T3 (da) Fremgangsmåder til fremstilling af forbindelsesled på grundlag af platin mellem markører og bioorganiske molekyler til mærkning af bioorganiske molekyler til påvisning af interessante biologiske stoffer
DK1238284T3 (da) Diagnostisk bestemmelse af slagtilfælde
IL127297A0 (en) Spruce budworm antifreeze proteins genes and methods of using same
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
DE60111906D1 (de) Verfahren zum Screenen von Pflanzenextrakten nach Wirkstoffen
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DE1210373T1 (de) Artverwandte-unabhängiger nachweis von microcystin- und nodularin-artverwandten
DE69033352T2 (de) Competitives enzym-testverfahren zum nachweis von phosphothioaten
NO20006192L (no) Angiostatin-bindingsprotein
Accomazzo et al. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties